Cita APA (7a ed.)

Chen, S., Yu, Q., & Zhou, S. (2021). Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Chen, Shubin, Qitao Yu, y Shaozhang Zhou. Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Chen, Shubin, et al. Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers Media S.A, 2021.